Abstract
ABSTRACTThree new series of photoluminescent nickel(II) metallomesogens, [NiL]; H2L = N,N′-Bis(4-n-alkoxysalicylidene)-4-fluoro/bromo/chloro-1,2-diaminobenzene (n = 12, 14, 16) based on ‘salphen’ ligands have been synthesised and their mesomorphic and photophysical properties explored. The complexes, isolated as orange microcrystalline solids were characterised by elemental analyses, FT-IR, 1H NMR and UV-visible spectroscopy. Thermal studies show all the compounds to be enantiotropic liquid crystals displaying columnar mesophase over a wide temperature range. Electronegativity and steric requirement of the halogen substituent at the ligand’s spacer remarkably influence the 2-D packing of the columns in the lattice in these complexes controlling the supramolecular mesomorphic order and photoluminescence. The mesophase behaviour of the fluoro-substituted complex is characterised by a transition from a columnar oblique (p1) to columnar rectangular (p2mm) phase, former stable till ambient temperature. The chloro and bromo analogues, on the other hand, displayed exclusively columnar rectangular (p2mm) mesophase with the former transforming into a glassy state and latter into a crystalline phase during cooling to ambient temperature. Molecular model based on interdigitated anti-parallel and back to back arrangements in the different columnar mesophase are proposed on the basis of X-ray diffraction (XRD) studies. The complexes emit in the blue region when excited with near UV wavelength.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.